#USA #Boston #blood collection #YourBio Health #TAP

YourBio Health: A New Era in Blood Collection

In a significant advancement for medical diagnostics, YourBio Health has recently announced the launch of its Scientific Medical Advisory Board (SMAB). This initiative aims to modernize blood collection practices and make diagnostic testing more accessible and painless. As a pioneer in the field with its innovative TAP® (Touch-Activated Phlebotomy) device, the company is set on a path to transforming how blood samples are collected worldwide.

A Powerful Partnership with Industry Leaders

YourBio Health has joined forces with eminent figures from institutions such as Harvard, Columbia, Thermo Fisher, and Helix. This collaboration reflects a united commitment to improve the patient experience by eliminating the fear associated with needle sticks – a common barrier to necessary medical testing. According to Michael Mina, Chief Scientific Officer at YourBio Health, about 20% of Americans avoid needle-related procedures, leading to missed diagnoses and increased healthcare costs.

The TAP® technology is employed not only in pediatric clinics but also in fertility centers, genetic testing facilities, and home health setups. With over a million TAP® devices already sold, the shift toward painless blood collection is gaining momentum. This SMAB will perform a crucial role, lending expertise in product development, clinical research, and the regulatory landscape, thus accelerating the deployment and efficacy of TAP® in various settings.

Addressing Critical Gaps in Healthcare

The newly formed advisory board consists of experts across multiple specialties, including pediatrics, maternal-fetal medicine, genomics, and digital health. Their vision is clear: create a future of diagnostics that transcends traditional blood collection methods. The board is split into two units: a Scientific Advisory Board, headed by Mina, and a Medical Advisory Board, led by Chet Robson, Chief Medical Officer at YourBio Health. This dual approach seeks to ensure that innovations remain grounded in ethical practices and robust scientific evidence.

Prominent members of the SMAB include renowned professionals like Zev Williams, MD, PhD, and Andrea G. Edlow, MD, MSc, who emphasize that the technological advancements brought forth by YourBio will pave the way for less traumatic patient experiences in the realm of diagnostics.

The Future of Diagnostics with TAP®

YourBio's ambition transcends merely providing an innovative product; it aims to set a new gold standard for blood collection. Dr. Edlow remarked that the fear induced by needle pricks can linger long after the clinical visit, accentuating the importance of versatility and gentleness in medical care. The seamless integration of TAP® across various healthcare platforms such as pediatric networks and pharmaceutical research and development showcases its transformative impact on traditional medical processes.

Zev Williams noted that the capabilities of TAP® represent not only a breakthrough in engineering but also signify a radical shift in how healthcare can be delivered. The emphasis on avoiding discomfort during necessary diagnostic tests is a core objective of the board, ensuring that no patient ever needs to dread a blood test again.

This bold vision is echoed by Robson and others who assert that the path forward should focus on reducing trauma, thereby supporting better health outcomes. With a dedicated mission to scale reach, enhance reimbursement strategies, and redefine blood sampling, YourBio Health is not just selling a product; it's building a future where diagnostic testing is both painless and precise.

About YourBio Health

Founded in 2011 with backing from Flagship Pioneering, YourBio Health is revolutionizing the medical device space with its innovative blood collection technology. The TAP® system eradicates the discomfort associated with traditional blood draws, allowing samples to be collected effortlessly and without the pain of a fingerstick. This human-centered approach aims to change the landscape of clinical trials and diagnostic testing, making blood collection more humane and accessible. YourBio Health's commitment to quality and innovation positions it as a leader in the rapidly evolving healthcare market.

With its SMAB in place and existing partnerships across multiple healthcare sectors, YourBio Health is poised to make a significant impact on how blood collection is approached, ensuring patient comfort and improving diagnostic outcomes globally.